Inventive Impex Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.95 M
- Company Age 15 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.55 Cr
- Satisfied Charges ₹ 4.80 Cr
- Revenue Growth %
- Profit Growth 115.99%
- Ebitda 25.81%
- Net Worth 0.03%
- Total Assets 0.02%
About Inventive Impex
Inventive Impex Private Limited (IIPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 September 2009 and has a history of 15 years and five months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.95 M.
The company currently has active open charges totaling ₹7.55 Cr. The company has closed loans amounting to ₹4.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shubham Bansal and Anju Aggarwal serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2009PTC193882
- Company No.
193882
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Sep 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Inventive Impex?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Bansal  | Director | 26-Oct-2020 | Current |
| Anju Aggarwal | Director | 26-Oct-2020 | Current |
Financial Performance of Inventive Impex.
Inventive Impex Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 115.99% increase in profit. The company's net worth moved up by a moderate rise of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Inventive Impex?
In 2023, Inventive Impex had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Inventive Medicare (India) LlpShubham Bansal is a mutual person
- Fibrient Healthcare Llp
Shubham Bansal is a mutual person
- Ethico Pharma Private Limited
Shubham Bansal is a mutual person
- Vsk Pharma Private Limited
Shubham Bansal is a mutual person
- Rj Global Ventures Llp
Anju Aggarwal is a mutual person
- Adorellecare Private Limited
Anju Aggarwal is a mutual person
Charges (Loans)
₹75.50 M
₹48.00 M
Charges Breakdown by Lending Institutions
- Others : 5.50 Cr
- Capital First Limited : 2.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2023 | Others | ₹5.50 Cr | Open |
| 25 Mar 2014 | Capital First Limited | ₹2.05 Cr | Open |
| 29 Nov 2022 | Hdfc Bank Limited | ₹2.00 Cr | Satisfied |
| 28 Dec 2018 | Hdfc Bank Limited | ₹2.80 Cr | Satisfied |
How Many Employees Work at Inventive Impex?
Unlock and access historical data on people associated with Inventive Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Inventive Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inventive Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
